Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:470-472

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foster, D. B.
Right arrow Articles by Van Eyk, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foster, D. B.
Right arrow Articles by Van Eyk, J. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Contractile function
Right arrow Genomics
Right arrow Ischemic biology - basic studies
(Circulation Research. 1999;85:470-472.)
© 1999 American Heart Association, Inc.


Editorial

In Search of the Proteins That Cause Myocardial Stunning

D. B. Foster, J. E. Van Eyk

From the Departments of Physiology (J.E.V.E.) and Biochemistry (D.B.F., J.E.V.E.), Queen's University, Kingston, Ontario, Canada.

Correspondence to Dr J.E. Van Eyk, Departments of Physiology and Biochemistry, Room 429 Botterell Hall, Queen's University, Kingston, Ontario, Canada K7L 3N6. E-mail JVE1@post.queensu.ca


Key Words: troponin I • protein modification • degradation • stunning • ischemia/reperfusion


*    Introduction
 
Cardiac diseases are characterized by a host of changes to the cellular processes that affect contractility of the heart. One emerging experimental approach to the study of cardiac disease, including the ischemia/reperfusion injury known as stunning, is to identify proteins that have been specifically altered or modified in the diseased state. Minimally, the identification of modified proteins will provide new diagnostic markers of myocyte injury. However, for a subset of proteins, disease-induced modification will substantively affect molecular function and contribute directly to cardiac dysfunction. Identification of these causative proteins will ultimately prove beneficial to the design of new pharmacological, genetic, or peptidomimetic therapies.

The complement and status of proteins within a myocyte (its protein profile) may be altered, through gene-mediated processes, which include isoform switching and the capacity to vary levels of protein expression, or through posttranslational modification, which includes phosphorylation and proteolysis among other processes. Protein function can also be perturbed under conditions of altered cellular homeostasis, which range from oxidative stress to cellular acidosis. In chronic disease, such as heart failure, the complexity of ongoing adaptive changes to cardiac function is mirrored at the molecular level. As a result, many, possibly hundreds of, proteins are subject to altered expression and/or posttranslational modification. In the acute phase of disease, however, dysfunction often precedes gene-mediated adaptive response, which suggests that the mechanism that underlies acute cardiac injury is attributable to a select few posttranslational events. This could well be the case for myocardial stunning, the subject of the article by . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. D. Gao, T. Dai, and D. Nyhan
Increased cross-bridge cycling rate in stunned myocardium
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H886 - H893.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kogler, D. G. Soergel, A. M. Murphy, and E. Marban
Maintained contractile reserve in a transgenic mouse model of myocardial stunning
Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2623 - H2630.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. McDonough, R. Labugger, W. Pickett, M. Y. Tse, S. MacKenzie, S. C. Pang, D. Atar, G. Ropchan, and J. E. Van Eyk
Cardiac Troponin I Is Modified in the Myocardium of Bypass Patients
Circulation, January 2, 2001; 103(1): 58 - 64.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. M. Murphy, H. Kögler, D. Georgakopoulos, J. L. McDonough, D. A. Kass, J. E. Van Eyk, and E. Marbán
Transgenic Mouse Model of Stunned Myocardium
Science, January 21, 2000; 287(5452): 488 - 491.
[Abstract] [Full Text]